Clinical significance of FABP2 expression in newborns with necrotizing enterocolitis

详细信息    查看全文

• 作者：Yu Liu ; Liang-Fu Jiang ; Rong-Peng Zhang ; Wen-Tong Zhang
• 关键词：fatty acid binding protein 2 ; meta ; analysis ; necrotizing enterocolitis of newborn ; protein expression
• 刊名：World Journal of Pediatrics
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：12
• 期：2
• 页码：159-165
• 全文大小：216 KB
• 参考文献：1.Panigrahi P. Necrotizing enterocolitis: a practical guide to its prevention and management. Paediatr Drugs 2006;8:151–165.CrossRef PubMed
  2.Josefsson S, Bunn SK, Domellöf M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44:407–413.CrossRef PubMed
  3.Björkström MV, Hall L, Söderlund S, Håkansson EG, Håkansson S, Domellöf M. Intestinal flora in very low-birth weight infants. Acta Paediatr 2009;98:1762–1767.CrossRef PubMed
  4.Däbritz J, Jenke A, Wirth S, Foell D. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr 2012;161:1059–1064.CrossRef PubMed
  5.Okogbule-Wonodi AC, Gross GW, Sun CC, Agthe AG, Xiao L, Waites KB, et al. Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res 2011;69:442–447.CrossRef PubMed PubMedCentral
  6.Terrin G, Passariello A, De Curtis M, Paludetto R, Berni Canani R. S100 A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child 2012;97:1102.CrossRef PubMed
  7.Gregory KE, Winston AB, Yamamoto HS, Dawood HY, Fashemi T, Fichorova RN, et al. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. J Pediatr 2014;164:1486–1488.CrossRef PubMed PubMedCentral
  8.Afrazi A, Sodhi CP, Richardson W, Neal M, Good M, Siggers R, et al. New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr Res 2011;69:183–188.CrossRef PubMed PubMedCentral
  9.Reisinger KW, Elst M, Derikx JP, Nikkels PG, De Vries B, Adriaanse MP, et al. Intestinal fatty acid-binding protein: a possible marker for gut maturation. Pediatr Res 2014;76:261–268.CrossRef PubMed
  10.Schurink M, Scholten IG, Kooi EM, Hulzebos CV, Kox RG, Groen H, et al. Intestinal fatty acid-binding protein in neonates with imminent necrotizing enterocolitis. Neonatology 2014;106:49–54.CrossRef PubMed
  11.Briana DD, Liosi S, Gourgiotis D, Boutsikou M, Baka S, Marmarinos A, et al. Cord blood intestinal fatty acid-binding protein (I-FABP) in full-term intrauterine growth restricted pregnancies. J Matern Fetal Neonatal Med 2012;25:2062–2065.CrossRef PubMed
  12.Aydemir C, Dilli D, Oguz SS, Ulu HO, Uras N, Erdeve O, et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev 2011;87:659–661.CrossRef PubMed
  13.Evennett NJ, Hall NJ, Pierro A, Eaton S. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010;45:735–740.CrossRef PubMed
  14.Rowland A, Knights KM, Mackenzie PI, Miners JO. Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parameters. Drug Metab Dispos 2009;37:1395–1403.CrossRef PubMed
  15.Reisinger KW, Derikx JP, Thuijls G, van der Zee DC, Brouwers HA, Van Bijnen AA, et al. Noninvasive measurement of intestinal epithelial damage at time of refeeding can predict clinical outcome after necrotizing enterocolitis. Pediatr Res 2013;73:209–213.CrossRef PubMed
  16.Thuijls G, Derikx JP, Van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010;251:1174–1180.CrossRef PubMed
  17.Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept 2008;147:25–28.CrossRef PubMed
  18.Derikx JP, Vreugdenhil AC, Van den Neucker AM, Grootjans J, Van Bijnen AA, Damoiseaux JG, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009;43:727–733.CrossRef PubMed
  19.Ng EW, Poon TC, Lam HS, Cheung HM, Ma TP, Chan KY, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013;258:1111–1118.CrossRef PubMed
  20.Reisinger KW, van der Zee DC, Brouwers HA, Kramer BW, Van Heurn LW, Buurman WA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 2012;47:1640–1645.CrossRef PubMed
  21.Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 2012;31:3805–3820.CrossRef PubMed PubMedCentral
  22.Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in metaanalysis. JAMA 2006;295:676–680.CrossRef PubMed
  23.Zintzaras E, Ioannidis JP. HEGESMA: genome search metaanalysis and heterogeneity testing. Bioinformatics 2005;21:3672–3673.CrossRef PubMed
  24.Qin JL, Wei H, Li LQ, Wang Y. The value of serum intestinal fatty acid binding protein in the diagnosis of necrotizing enterocolitis. Chin J Pediatr Surg 2013;34:590–594. [In Chinese]
  25.Li C, Ren XY, Cai WX, Niu FH. Cytokines and intestinal fatty acid binding protein for early diagnosis and determination of the severity of necrotizing enterocolitis. Shandong Medical J 2013;53:50–51. [In Chinese]
  26.Derikx JP, Evennett NJ, Degraeuwe PL, Mulder TL, Van Bijnen AA, Van Heurn LW, et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 2007;56:1473–1475.CrossRef PubMed PubMedCentral
  27.Guthmann F, Börchers T, Wolfrum C, Wustrack T, Bartholomäus S, Spener F. Plasma concentration of intestinal-and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 2002;239:227–234.CrossRef PubMed
  28.Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002;22:5114–5127.CrossRef PubMed PubMedCentral
  29.Evennett N, Alexander N, Petrov M, Pierro A, Eaton S. A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis. J Pediatr Surg 2009;44:2192–2201.CrossRef PubMed
  
• 作者单位：Yu Liu (1) (2)
  Liang-Fu Jiang (2)
  Rong-Peng Zhang (2)
  Wen-Tong Zhang (1) (2) (3)
  
  1. Department of Pediatric Surgery, Qilu Hospital, Shandong Univeristy, Ji’nan, China
  2. Department of Pediatric Surgery, Linyi People’s Hospital affiliated to Shandong Univeristy, Linyi, China
  3. Department of Pediatric Surgery, Qilu Hospital, Shandong Univeristy, No. 106 West of Wenhua Road, Ji’nan, 250012, China
  
• 刊物主题：Pediatrics; Pediatric Surgery; Maternal and Child Health; Intensive / Critical Care Medicine; Surgery; Imaging / Radiology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1867-0687

文摘

Background This meta-analysis aimed to determine the role of human fatty acid binding protein 2 (FABP2) expression in the diagnosis of necrotizing enterocolitis (NEC) of newborns.